<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4798043</article-id><article-id pub-id-type="publisher-id">554</article-id><article-id pub-id-type="doi">10.1186/2197-425X-3-S1-A410</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Comparison of neurally adjusted ventilatory assist and pressure support ventilation during the early phase of weaning from mechanical ventilation - a randomised controlled study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Demoule</surname><given-names>A</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Clavel</surname><given-names>M</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Rolland-Debord</surname><given-names>C</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Perbet</surname><given-names>S</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Terzi</surname><given-names>N</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Kouatchet</surname><given-names>A</given-names></name><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Wallet</surname><given-names>F</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Guerin</surname><given-names>C</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Roze</surname><given-names>H</given-names></name><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Vargas</surname><given-names>F</given-names></name><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Dellamonica</surname><given-names>J</given-names></name><xref ref-type="aff" rid="Aff11"/></contrib><contrib contrib-type="author"><name><surname>Jaber</surname><given-names>S</given-names></name><xref ref-type="aff" rid="Aff12"/></contrib><contrib contrib-type="author"><name><surname>Similowski</surname><given-names>T</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><aff id="Aff1"><label/>Groupe Hospitalier Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re, Paris, France </aff><aff id="Aff2"><label/>UMRS 1158, INSERM and Pierre and Marie Curie University, Paris, France </aff><aff id="Aff3"><label/>H&#x000f4;pital Dupuytren, Limoges, France </aff><aff id="Aff4"><label/>H&#x000f4;pital D'Estaing, Clermont-Ferrand, France </aff><aff id="Aff5"><label/>CHU C&#x000f4;te de Nacre, Caen, France </aff><aff id="Aff6"><label/>CHRU, Angers, France </aff><aff id="Aff7"><label/>Centre Hospitalier Lyon-Sud, Lyon, France </aff><aff id="Aff8"><label/>H&#x000f4;pital de la Croix Rousse, Lyon, France </aff><aff id="Aff9"><label/>CHU de Bordeaux, Pessac, France </aff><aff id="Aff10"><label/>Hopital Pellegrin - CHU de Bordeaux, Bordeaux, France </aff><aff id="Aff11"><label/>H&#x000f4;pital de l'Archet, Nice, France </aff><aff id="Aff12"><label/>H&#x000f4;pital Saint-Eloi, Montpellier, France </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>3</volume><issue>Suppl 1</issue><issue-sponsor>The publication charges for this supplement were funded by Intensive Care Medicine Experimental.</issue-sponsor><elocation-id>A410</elocation-id><permissions><copyright-statement>&#x000a9; Demoule et al.; 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><conference><conf-name>ESICM LIVES 2015</conf-name><conf-loc>Berlin, Germany</conf-loc><conf-date>3-7 October 2015</conf-date><string-conf><uri>http://www.esicm.org/</uri></string-conf></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Rational</title><p>Neurally adjust ventilatory assist (NAVA) is a ventilatory mode that tailors the level of assistance delivered by the ventilator to the electromyographic activity of the diaphragm. Physiological studies have demonstrated the benefit of NAVA on patient ventilator interactions and prevention of lung over inflation. However, clinical data are currently lacking.</p></sec><sec id="Sec2"><title>Objectives</title><p>To compare NAVA and Pressure Support Ventilation (PSV) at the early phase of ventilator weaning in patients recovering from an acute respiratory failure.</p></sec><sec id="Sec3"><title>Patients and Methods</title><p>A multicenter randomized controlled trial of 128 intubated adults (median [IQR] age, 66 [57-77] years) was conducted in 11 intensive care units in France from April 2010 to June 2012. Patients were included as soon as they could tolerate PSV with a PS level &#x02264;30 cmH2O, a PEEP &#x02264;8 cmH2O and a FiO2 &#x02264;50%. Patients were randomly assigned to NAVA (n = 62) or PSV (n = 66). The PS level in the PSV group and the NAVA level in the NAVA group were set to obtain a tidal volume of 6-8 ml/kg. The primary end point was the probability to remain in an assist mode during the entire first 48 hours. Secondary end points were duration of mechanical ventilation and 28 days mortality.</p></sec><sec id="Sec4"><title>Results</title><p>67.2% (n = 45) in the NAVA group vs. 63.3% (n = 44) in the PSV group (p = 0.66).. The time spend in an assist mode during the first 48 hours was 47 [43-48] hours in the NAVA group vs. 47 [40-48] hours in the PSV group (p = 0.55). The asynchrony index was lower in the NAVA group (19.7% vs. 32.6%), so was the prevalence of dyspnea at day-1 (9% vs. 19%). The time to first extubation was 7 [2-10] days in the NAVA group vs. 7 [2-10] days in the PSV group (p = 0.78). The hospital mortality rate in the NAVA group was 14.5% (n = 9) vs. 21.2% (n = 14) in the PSV group (p = 0.2). NAVA and PSV were associated to similar oxygenation. NAVA was not associated with any adverse event.</p></sec><sec id="Sec5"><title>Conclusions</title><p>NAVA can be applied efficiently in a clinical setting and improves patient ventilator interaction. However, NAVA does not increase the probability to remain in an assisted mode nor it reduces hospital mortality.</p></sec></body></article>